163 related articles for article (PubMed ID: 23478972)
21. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
Tarazona R; Blewett DA; Carmona MD
Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
[TBL] [Abstract][Full Text] [Related]
22. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
23. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
24. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
Rueda C; Fenoy S; Simón F; Del Aguila C
Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
[TBL] [Abstract][Full Text] [Related]
25. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
[No Abstract] [Full Text] [Related]
26. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.
Rossignol JF; Ayoub A; Ayers MS
J Infect Dis; 2001 Jul; 184(1):103-6. PubMed ID: 11398117
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.
Kirubakaran S; Gorla SK; Sharling L; Zhang M; Liu X; Ray SS; Macpherson IS; Striepen B; Hedstrom L; Cuny GD
Bioorg Med Chem Lett; 2012 Mar; 22(5):1985-8. PubMed ID: 22310229
[TBL] [Abstract][Full Text] [Related]
29. Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.
Costa LB; JohnBull EA; Reeves JT; Sevilleja JE; Freire RS; Hoffman PS; Lima AA; Oriá RB; Roche JK; Guerrant RL; Warren CA
J Parasitol; 2011 Dec; 97(6):1113-20. PubMed ID: 21711105
[TBL] [Abstract][Full Text] [Related]
30. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
Rasmussen KR; Healey MC; Cheng L; Yang S
J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
[TBL] [Abstract][Full Text] [Related]
32. Nitazoxanide treatment of Cryptosporidium parvum in human immunodeficiency virus-infected children.
Capparelli EV; Syed SS
Pediatr Infect Dis J; 2008 Nov; 27(11):1041. PubMed ID: 18818555
[No Abstract] [Full Text] [Related]
33. Infectivity of gastric and intestinal Cryptosporidium species in immunocompetent Mongolian gerbils (Meriones unguiculatus).
Kvác M; Sak B; Kvetonová D; Secor WE
Vet Parasitol; 2009 Jul; 163(1-2):33-8. PubMed ID: 19394145
[TBL] [Abstract][Full Text] [Related]
34. Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children.
Abraham DR; Rabie H; Cotton MF
Pediatr Infect Dis J; 2008 Nov; 27(11):1040-1. PubMed ID: 18985834
[No Abstract] [Full Text] [Related]
35. Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.
Umejiego NN; Gollapalli D; Sharling L; Volftsun A; Lu J; Benjamin NN; Stroupe AH; Riera TV; Striepen B; Hedstrom L
Chem Biol; 2008 Jan; 15(1):70-7. PubMed ID: 18215774
[TBL] [Abstract][Full Text] [Related]
36. Pomegranate (Punica granatum) peel is effective in a murine model of experimental Cryptosporidium parvum.
Al-Mathal EM; Alsalem AM
Exp Parasitol; 2012 Jul; 131(3):350-7. PubMed ID: 22580265
[TBL] [Abstract][Full Text] [Related]
37. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
Moustafa MA
J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
[TBL] [Abstract][Full Text] [Related]
38. ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION.
Abaza BE; Hamza RS; Farag TI; Abdel-Hamid MA; Moustafa RA
J Egypt Soc Parasitol; 2016 Dec; 46(3):683-692. PubMed ID: 30230765
[TBL] [Abstract][Full Text] [Related]
39. Curative and preventive anticryptosporidium activities of sinefungin in an immunosuppressed adult rat model.
Brasseur P; Lemeteil D; Ballet JJ
Antimicrob Agents Chemother; 1993 Apr; 37(4):889-92. PubMed ID: 8494386
[TBL] [Abstract][Full Text] [Related]
40. Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
Giacometti A; Cirioni O; Barchiesi F; Ancarani F; Scalise G
J Antimicrob Chemother; 2000 Apr; 45(4):453-6. PubMed ID: 10747821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
